Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component Open Access Deposited

Downloadable Content

Download PDF
Download Adobe Acrobat Reader
Date Uploaded: 03/01/2017
Date Modified: 04/07/2017

Organovanadium compounds have been shown to be insulin sensitizers in vitro and in vivo. One potential biochemical mechanism for insulin sensitization by these compounds is that they inhibit protein tyrosine phosphatases (PTPs) that negatively regulate insulin receptor activation and signaling. In this study, bismaltolato oxovanadium (BMOV), a potent insulin sensitizer, was shown to be a reversible, competitive phosphatase inhibitor that inhibited phosphatase activity in cultured cells and enhanced insulin receptor activation in vivo. NMR and X-ray crystallographic studies of the interaction of BMOV with two different phosphatases, HCPTPA (human low molecular weight cytoplasmic protein tyrosine phosphatase) and PTP1B (protein tyrosine phosphatase 1B), demonstrated uncomplexed vanadium (VO ) in the active site. Taken together, these findings support phosphatase inhibition as a mechanism for insulin sensitization by BMOV 4 and other organovanadium compounds and strongly suggest that uncomplexed vanadium is the active component of these compounds.

Date Created
Journal Title
  • Journal of Inorganic Biochemistry
  • This work was part of a pilot "mediated-deposit model" where library staff found potential works, later submitted for faculty review

Digital Object Identifier (DOI)

Identifier: 10.1016/S0162-0134(03)00236-8

This DOI link is the best way for others to cite your work.


Permanent link to this page: